Search

Displaying results 1031 - 1040 of 10000 in total
  1. Drug

    Pergolide

    go.drugbank.com/drugs/DB01186
    ApprovedVet approvedWithdrawn

    The drug was withdrawn from the US market in March 2007 and from the Canadian market in August 2007.

    Products: PERGOLID-NEURAX 1 MG, PERGOLID-NEURAX 0.25 MG
  2. Drug

    Cysteamine

    go.drugbank.com/drugs/DB00847
    ApprovedInvestigational

    [L15611] On August 25th 2020, the first ophthalmic solution for cystinosis requiring only 4 daily treatments was granted FDA approval.

    Products: CYSTAGON ® 150 MG, CYSTADROPS® 3.8 MG/ML SOLUCIÓN OFTÁLMICA
  3. Drug

    EGT-201

    go.drugbank.com/drugs/DB17648
    Experimental

    EGT-201 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of the alpha-N-acetyglucosaminidase (NAGLU) transgene.

    Synonyms: EGT 201
  4. Drug

    Nizatidine

    go.drugbank.com/drugs/DB00585
    Approved

    A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers.

    Products: AXID INYECTABLE 100 MG/4 ML, AXID CAPSULAS 300 MG
  5. Drug

    Desogestrel

    go.drugbank.com/drugs/DB00304
    ApprovedInvestigational

    Desogestrel, a prodrug, is a third generation progestogen and hence, a member of the gonane family which was largely used in Europe before being approved in the US and Canada. It was firstly generated from a study that showed that 11-bet...

    Synonyms: 13-Ethyl-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-17-olMixtures: Liberel 0,15 mg/0,03 mg Filmtabletten, Desofemine 20 Mikrogramm/150 Mikrogramm Filmtabletten
  6. Drug

    Ipriflavone

    go.drugbank.com/drugs/DB13618
    Investigational

    Products: OSTEOFLAVONATABLETASX 200 MG, IPRIFLAVONA TABLETAS 200 MG
  7. Drug

    Epinastine

    go.drugbank.com/drugs/DB00751
    Approved

    Epinastine is used for the prevention of itching associated with allergic conjunctivitis. It has a multi-action effect that inhibits the allergic response in 3 ways: 1. stabilizes mast cells by preventing mast cell degranulation to contr...

    Products: FLURINOL ® JARABE 0.2 G / 100 ML, Relestat 0,5 mg/ml Augentropfen
  8. Drug

    Methylene blue

    go.drugbank.com/drugs/DB09241
    ApprovedInvestigational

    Methylene blue is an oxidation-reduction agent. The intravenous form of methylene blue is approved by the FDA for the treatment of pediatric and adult patients with acquired methemoglobinemia. Historically, it has been widely used in Afr...

    Mixtures: Me NaPhos MB Hyo 1, Uro-MPProducts: BLUMET 100 MG/10 ML IV ENJEKSIYON IÇIN ÇÖZELTI IÇEREN AMPUL ,1 AMPUL, BLUMET 50 MG/5 ML IV ENJEKSIYON IÇIN ÇÖZELTI IÇEREN AMPUL ,1 AMPUL
  9. Drug

    Cabotegravir

    go.drugbank.com/drugs/DB11751
    ApprovedInvestigational

    Cabotegravir, or GSK1265744, is an HIV-1 integrase inhibitor that is prescribed with the non-nucleoside reverse transcriptase inhibitor, rilpivirine. Early research into cabotegravir showed it had lower oral bioavailability than dolutegr...

    Products: Vocabria 400 mg/2 ml Enjeksiyonluk Uzatılmış Salımlı Süspansiyon, 1 ADET, Vocabria 600 mg/3 ml Enjeksiyonluk Uzatılmış Salımlı Süspansiyon, 1 ADET
  10. Drug

    CX-2009

    go.drugbank.com/drugs/DB16090
    Investigational

    CX-2009 is under investigation in clinical trial NCT03149549 (PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors).

    Synonyms: Anti-cd166 probody-drug conjugate cx-2009